Federal Judge OKs Benzene Class Action to Proceed Over Differin Acne Product's Manufacturing Practices
The plaintiff, Skylar Williams, accused Galderma Laboratories of producing a skin-care line that contains benzene. In one of ...
No observations by US FDA during plant inspection: DRL
Dr. Reddy's Laboratories announced that the U.S. Food & Drug Administration (FDA) completed a routine Good Manufacturing ...
cnbctv182d
US FDA has no adverse observations after scan of Dr Reddy's Hyderabad R&D unit
The United States Food & Drug Administration (FDA) did a routine Good Manufacturing Practice (GMP) inspection at Dr Reddy's ...
Torrent Pharmaceuticals Receives Form 483 From US FDA After Inspection
"At the end of the inspection, the agency issued a Form FDA 483 with one observation which is procedural in nature," it added ...
Maggots, other violations reported at North Carolina drug factory
A drug production facility in Durham run by a Chinese company violated multiple safety regulations, according to the FDA. A ...
MedPage Today4d
Eye Drop Company in FDA's Sights Once Again
In its latest warning letter, FDA raised concern that the company was still producing eye drops with amniotic fluid, even ...
Night Helper Blog LLC on MSN3d
Kerassentials (Our Expert Review) Does It Really Work For Toenail Fungus Relief?
Kerassentials is a novel formula designed to combat antifungal resistance and alleviate toenail itching. The formula h ...
Food Safety News13d
FDA issues warnings to water company over mold contamination and infant formula producer lacking Cronobacter testing
The Food and Drug Administration sends warning letters to entities under its jurisdiction as part of its enforcement ...
devdiscourse7d
USFDA Flags Major Manufacturing Lapses at Zydus Lifesciences
The US Food and Drug Administration (USFDA) has issued a warning letter to Zydus Lifesciences for significant violations of good manufacturing practices at their Gujarat facility. The letter points ...
JD Supra12d
Weight Loss Drug Shortages Will End Soon
On August 8, 2024, the US Food and Drug Administration (FDA) partially revised the availability of certain glucagon-like peptide 1 (GLP-1) ...
Dr. Reddy’s R&D centre in Hyderabad completes US FDA inspection
Dr. Reddy's Hyderabad R&D centre passes USFDA inspection with zero observations, ensuring compliance with GMP standards.
Daewoong unveils new Indonesian stem cell facility with GMP certification
South Korean drug maker Daewoong Pharmaceutical has announced the launch of a new stem cell plant in Indonesia, marking the ...